• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种用于人类调节性T细胞功能分析的优化方法。

An optimized method for the functional analysis of human regulatory T cells.

作者信息

Oberg H-H, Wesch D, Lenke J, Kabelitz D

机构信息

Institute of Immunology, University Hospital Schleswig-Holstein, Michaelisstrasse 5, D-24105 Kiel, Germany.

出版信息

Scand J Immunol. 2006 Sep;64(3):353-60. doi: 10.1111/j.1365-3083.2006.01825.x.

DOI:10.1111/j.1365-3083.2006.01825.x
PMID:16918705
Abstract

Naturally occurring regulatory T cells (Treg) suppress the activation of antigen-responsive T cells in a cell contact-dependent manner. In order to investigate the impact of soluble mediators and receptor-ligand interactions on the interplay between naive T cells and Treg, a reproducible suppressor cell assay which functions in the absence of additional feeder cells or antigen-presenting cells is mandatory. Here, we describe such a method which is suited to study the modulation of responder T cell/Treg interactions in vitro. Treg were isolated from negatively purified total human CD4+ T cells by positive selection using anti-CD25 monoclonal antibody (MoAb)-coated Dynabeads followed by a detachment step. The remaining CD4+ CD25- responder T cells were cocultured with CD4+ CD25+ Treg in the presence of T-cell Activation/Expansion Beads from Miltenyi Biotec pre-coated with anti-CD3 plus anti-CD28 monoclonal antibody (MoAb). The optimal concentration for coating was 5 microg/ml for both MoAb. At this concentration, strong proliferation of responder T cells was elicited which was almost completely suppressed by Treg at 1:1 cell ratios. When higher concentrations of anti-CD3/anti-CD28 MoAb were used for coating, Treg also showed some degree of proliferation. The optimized suppressor assay proved to be highly reproducible and was used here to confirm the partial or complete reversal of Treg-mediated T-cell suppression by some cytokines (IL-2, IL-15), soluble IL-6 receptor/IL-6 fusion protein and recombinant GITR-ligand. Furthermore, our data confirm that Treg do not need other cell types to suppress proliferation of CD4+ CD25- responder T cells.

摘要

天然存在的调节性T细胞(Treg)以细胞接触依赖的方式抑制抗原反应性T细胞的激活。为了研究可溶性介质和受体-配体相互作用对幼稚T细胞和Treg之间相互作用的影响,必须建立一种在没有额外饲养细胞或抗原呈递细胞的情况下仍能发挥作用的可重复抑制细胞测定法。在此,我们描述了一种适用于体外研究反应性T细胞/Treg相互作用调节的方法。通过使用抗CD25单克隆抗体(MoAb)包被的Dynabeads进行阳性选择,然后进行分离步骤,从阴性纯化的人总CD4 + T细胞中分离出Treg。将剩余的CD4 + CD25 - 反应性T细胞与CD4 + CD25 + Treg在预先包被有抗CD3加抗CD28单克隆抗体(MoAb)的Miltenyi Biotec公司的T细胞激活/扩增磁珠存在下共培养。两种MoAb的最佳包被浓度均为5μg/ml。在此浓度下,可引发反应性T细胞的强烈增殖,而在1:1细胞比例下,Treg几乎完全抑制了这种增殖。当使用更高浓度的抗CD3/抗CD28 MoAb进行包被时,Treg也表现出一定程度的增殖。优化后的抑制测定法被证明具有高度可重复性,并在此用于确认某些细胞因子(IL-2、IL-15)、可溶性IL-6受体/IL-6融合蛋白和重组GITR配体对Treg介导的T细胞抑制的部分或完全逆转。此外,我们的数据证实,Treg不需要其他细胞类型来抑制CD4 + CD25 - 反应性T细胞的增殖。

相似文献

1
An optimized method for the functional analysis of human regulatory T cells.一种用于人类调节性T细胞功能分析的优化方法。
Scand J Immunol. 2006 Sep;64(3):353-60. doi: 10.1111/j.1365-3083.2006.01825.x.
2
Functional assay for human CD4+CD25+ Treg cells reveals an age-dependent loss of suppressive activity.人类CD4+CD25+调节性T细胞的功能检测揭示了其抑制活性的年龄依赖性丧失。
J Neurosci Res. 2003 Oct 15;74(2):296-308. doi: 10.1002/jnr.10766.
3
Dendritic cells partially abrogate the regulatory activity of CD4+CD25+ T cells present in the human peripheral blood.树突状细胞部分消除了人外周血中存在的CD4+CD25+ T细胞的调节活性。
Int Immunol. 2007 Mar;19(3):227-37. doi: 10.1093/intimm/dxl139. Epub 2007 Feb 7.
4
Proinflammatory mediator-induced reversal of CD4+,CD25+ regulatory T cell-mediated suppression in rheumatoid arthritis.促炎介质诱导类风湿关节炎中CD4 +、CD25 +调节性T细胞介导的抑制作用逆转
Arthritis Rheum. 2007 Mar;56(3):732-42. doi: 10.1002/art.22414.
5
Targeting acute allograft rejection by immunotherapy with ex vivo-expanded natural CD4+ CD25+ regulatory T cells.通过体外扩增的天然CD4+CD25+调节性T细胞免疫疗法靶向急性同种异体移植排斥反应。
Transplantation. 2006 Dec 27;82(12):1749-55. doi: 10.1097/01.tp.0000250731.44913.ee.
6
IL-2-independent generation of FOXP3(+)CD4(+)CD8(+)CD25(+) cytotoxic regulatory T cell lines from human umbilical cord blood.从人脐带血中不依赖白细胞介素-2生成FOXP3(+)CD4(+)CD8(+)CD25(+)细胞毒性调节性T细胞系
Exp Hematol. 2007 Feb;35(2):287-96. doi: 10.1016/j.exphem.2006.10.011.
7
In vitro expanded human CD4+CD25+ regulatory T cells are potent suppressors of T-cell-mediated xenogeneic responses.体外扩增的人CD4+CD25+调节性T细胞是T细胞介导的异种反应的有效抑制因子。
Transplantation. 2008 Jun 27;85(12):1841-8. doi: 10.1097/TP.0b013e3181734793.
8
In vivo expansion of CD4+Foxp3+ regulatory T cells mediated by GITR molecules.由糖皮质激素诱导的肿瘤坏死因子受体(GITR)分子介导的CD4+Foxp3+调节性T细胞的体内扩增。
Immunol Lett. 2008 Dec 22;121(2):97-104. doi: 10.1016/j.imlet.2008.09.003. Epub 2008 Oct 18.
9
GITR ligand-costimulation activates effector and regulatory functions of CD4+ T cells.糖皮质激素诱导肿瘤坏死因子受体配体共刺激激活CD4+T细胞的效应和调节功能。
Biochem Biophys Res Commun. 2008 May 16;369(4):1134-8. doi: 10.1016/j.bbrc.2008.03.024. Epub 2008 Mar 17.
10
A CFSE based assay for measuring CD4+CD25+ regulatory T cell mediated suppression of auto-antigen specific and polyclonal T cell responses.一种基于羧基荧光素二乙酸琥珀酰亚胺酯(CFSE)的检测方法,用于测量CD4+CD25+调节性T细胞介导的对自身抗原特异性和多克隆T细胞反应的抑制作用。
J Immunol Methods. 2007 Apr 30;322(1-2):1-11. doi: 10.1016/j.jim.2007.01.025. Epub 2007 Mar 5.

引用本文的文献

1
Phenotypic and Functional Studies of Human Treg Cell Subpopulations.人类调节性 T 细胞亚群的表型和功能研究。
Methods Mol Biol. 2023;2559:153-169. doi: 10.1007/978-1-0716-2647-4_11.
2
Phenotype and regulation of immunosuppressive Vδ2-expressing γδ T cells.免疫抑制性 Vδ2 表达 γδ T 细胞的表型和调控。
Cell Mol Life Sci. 2014 May;71(10):1943-60. doi: 10.1007/s00018-013-1467-1. Epub 2013 Oct 4.
3
Regulatory T-cells and associated pathways in metastatic renal cell carcinoma (mRCC) patients undergoing DC-vaccination and cytokine-therapy.
调节性 T 细胞及相关通路在转移性肾细胞癌(mRCC)患者接受树突状细胞疫苗接种和细胞因子治疗中的作用。
PLoS One. 2012;7(10):e46600. doi: 10.1371/journal.pone.0046600. Epub 2012 Oct 31.
4
In vivo inhibition of human CD19-targeted effector T cells by natural T regulatory cells in a xenotransplant murine model of B cell malignancy.在 B 细胞恶性肿瘤的异种移植鼠模型中,天然 T 调节细胞对人 CD19 靶向效应 T 细胞的体内抑制作用。
Cancer Res. 2011 Apr 15;71(8):2871-81. doi: 10.1158/0008-5472.CAN-10-0552. Epub 2011 Apr 12.
5
Antagonistic and agonistic anti-canine CD28 monoclonal antibodies: tools for allogeneic transplantation.拮抗和激动型抗犬 CD28 单克隆抗体:同种异体移植的工具。
Transplantation. 2011 Apr 27;91(8):833-40. doi: 10.1097/TP.0b013e31820f07ff.
6
Influence of serum and soluble CD25 (sCD25) on regulatory and effector T-cell function in hepatocellular carcinoma.血清和可溶性 CD25(sCD25)对肝癌调节性和效应 T 细胞功能的影响。
Scand J Immunol. 2010 Oct;72(4):293-301. doi: 10.1111/j.1365-3083.2010.02427.x.
7
Autoantigen-specific regulatory T cells induced in patients with type 1 diabetes mellitus by insulin B-chain immunotherapy.胰岛素 B 链免疫疗法诱导 1 型糖尿病患者自身抗原特异性调节性 T 细胞。
J Autoimmun. 2010 Jun;34(4):408-15. doi: 10.1016/j.jaut.2009.10.005.
8
Clinical and immunologic effects of intranodal autologous tumor lysate-dendritic cell vaccine with Aldesleukin (Interleukin 2) and IFN-{alpha}2a therapy in metastatic renal cell carcinoma patients.淋巴结内自体肿瘤裂解物-树突状细胞疫苗联合阿地白介素(白细胞介素2)及干扰素-α2a治疗转移性肾细胞癌患者的临床和免疫学效应
Clin Cancer Res. 2009 Aug 1;15(15):4986-92. doi: 10.1158/1078-0432.CCR-08-3240. Epub 2009 Jul 21.
9
Regulatory T cells and their role in rheumatic diseases: a potential target for novel therapeutic development.调节性 T 细胞及其在风湿性疾病中的作用:新型治疗开发的潜在靶点。
Pediatr Rheumatol Online J. 2008 Dec 1;6:20. doi: 10.1186/1546-0096-6-20.